View Older Stories
-
CVS Health (CVS) PT Raised to $72 at Citi
-
CVS Health (CVS) PT Raised to $74 at Citi
-
CVS Health (CVS) PT Lowered to $68 at Citi
-
Cooperman's Omega Raises Cigna (CI), CVS (CVS); Lowers Google (GOOGL) (more...) - 13F
-
CVS Health (CVS) PT Raised to $94 at Citi
-
Pre-Open Movers 07/31: (NAKD) (MX) (IVAC) Higher; (LL) (VRNS) (TXRH) Lower (more...)
-
Citi Assumes CVS Health (CVS), Upgrades to Buy
-
Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more...) -13F
-
CVS Health (CVS) PT Lowered to $68 at Citi
-
Pre-Open Movers 05/08: (PI) (VRX) (FRED) Higher; (NVRO) (IONS) (AKCA) Lower (more...)
-
After-Hours Stock Movers 05/07: (FRED) (VECO) (FN) Higher; (NVRO) (INWK) (HTZ) Lower (more...)
-
Glenview Capital 13F Shows New Stakes in Allergan (AGN), Newell (NWL), Charter (CHTR) Aramark (ARMK) (More...)
-
CVS Health (CVS) PT Lowered to $77 at Citi
-
CVS Health (CVS) PT Raised to $80 at Citi
-
Dow hits record as investors bet on tax cuts
-
Glenview Capital Enters Comcast (CMCSA), CVS (CVS), Twitter (TWTR) (more...) - 13F
-
Factors of Influence in 2018, Key Indicators and Opportunity within Citigroup, Caesars Entertainment, 3M, First Industrial Realty, Nutanix, and CVS Health – New Research Emphasizes Economic Growth
-
S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017
-
Notable Mergers and Acquisitions 6/15: (CVS)/(TGT) (NKA) (RYL)/(SPF) (TRAK) (DSKY)
-
Top 10 News for 5/18 - 5/22: Fed Rate Hike Pushed Back; Icahn Calls for More Apple Buybacks; Big Banks Settle FX Probe
-
Citi Starts CVS Health (CVS) at Neutral
-
Cooperman's Omega Advisors Shows New Stakes in Facebook (FB), Crocs (CROX) and Freeport-McMoRan (FCX)
-
Notable 52-Week Highs and Lows of the Day 12/13: (CVS) (INFI) (CLSN) High; (RIGL) Low
-
Cooperman's Omega Shows New Stakes in Atmel (ATML), Ctrip.com (CTRP), Tivo (TIVO), Walgreen (WAG), more...
-
Cooperman's Omega Shows New Express Scripts (ESRX), McDermott (MDR) Stakes; Boosts AIG (AIG), Sirius XM (SIRI); Cuts Citi (C)
-
Notable Analyst Rating Changes 08/08: (CE) (AKS) (CVS) Upgraded; (MGM) (IAG) (FOSL) Downgraded
-
Notable Analyst Rating Changes 07/12: (MRK) (SVU) (CVX) Upgraded; (ADTN) (TSL) (TSN) Downgraded
-
Notable Analyst Rating Changes 03/13: (NWY) (AIV) (SNI) Upgraded; (MANT) (CVC) (VCI) Lower
-
Paulson & Co. Trims Some Gold (GLD) and Exits Banks in a Big Way (BAC) (C) (WFC)
-
Citi Adds CVS (CVS) to 'Top Picks Live' List Ahead of Q4 Results
-
Barclays 2012 Top Picks: Becoming Somewhat More Optimistic - Signs of Progress, Growth and Soft Landings
-
Paulson's Paulson & Co. Releases Q3 2011 13F
-
Notable Analyst Rating Changes 11/04: (FSLR) (CVS) (MCHP) Upgraded; (FTR) (CHS) (COH) Downgraded
-
Citi Says Buy CVS (CVS) Ahead of Q3 Results as Walgreen/Express Scripts Talks Ongoing
-
Glenview Capital Shows New Stakes in BofA (BAC), AIG (AIG) and Crown Castle (CCI); Sells CVS (NYSE: CVS), Pfizer (PFE)
-
Cooperman's Omega Advisors Shows Lower Tech Exposure, Raises Bet on Consumer Electronic Sales
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Cooperman's Omega Advisors Shows New Stakes In BofA (BAC) and Verizon (VZ)
-
Daily State of the Markets 01/31: Lots of Excuses, But...
-
Notable Analyst Rating Changes 12/07: UN, WTW, STP, RHT Upgraded; RIMM, NGD, INTC, FIRE Downgraded
-
George Soros' 13F Shows New Stakes in Dendreon, Dow, Citi, Raised Stakes in Plains Exploration, Teva, Verizon, AT&T, Pfizer, JPMorgan
-
Citi Tidbit From 2010 NACDS Pharmacy & Technology Conference
-
Notable 52-Week High's and Low's of the Day 07/28: BRCM, APL, CHRW, SIMG High; MHS, ALTH, FORM, DJSP Low
-
Citi Analyst: CVS Reaches Agreement to End Channel Conflict; Reiterates 'Buy'; Walgreen Gets 'Sell' Rating
-
Citi Comments on Pharmacy Benefit Management's (PBM) - Bad is Good, But Real Bad is Bad
-
Citi Reiterates a 'Buy' on CVS Caremark (CVS), Remains 'Top Pick'
-
Goldman Sachs' Hedge Fund VIP List (CIT, CF, ACL, GILD, more...)
-
Notable Analyst Rating Changes 05/20: ARUN, Q, CHS, WFC Upgraded; SYMC, RIMM, WAG Downgraded
-
Citi Reiterates a 'Buy' on CVS Caremark Corp (CVS); Key Takes from Our Meeting w/PBM
-
Citi Key Takes From Meeting w/Pharmacy Benefit Management (PBMs) Leader at Buck Consultants